Abe Y., Ito T., et al. An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study) . Future Oncol. 2024 Feb 29. doi: 10.2217/fon-2023-0834.

Miyashita N., Ito T., et al. Aspiration pneumonia was the most frequent cause of death in older patients with SARS-CoV-2 omicron-related pneumonia in Japan. J Am Geriatr Soc. 2024 Mar 7. doi: 10.1111/jgs.18852.

Shimazu Y., Ito T., et al.Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin. Sci Rep. 2023; 13: 5159.

Miyashita N., Ito T., et al. Functional decline at 1 year in hospitalized elderly pneumonia with SARS-CoV-2 Omicron variant: Comparison with the ancestral strain and Alpha variant. Influenza Other Respir Viruses. 2024 Feb; 18(2): e13251.

Kuwana, M., Ito, T., et al.Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study.Am J Hematol. 2024 Feb;99(2):E55-E59.

Miyashita N., Ito T., et al. Comparison of pneumonia severity scores for COVID-19 patients with the Omicron variant. J Infect Chemother . 2023 Nov 10:S1341-321X(23)00279-9.

Nakaya A., Ito T., et al.Impact of cytogenetic abnormalities in symptomatic multiple myeloma; a Japanese real-world analysis from Kansai Myeloma Forum. Leuk Res Rep. 2023 Nov 17:20:100395.

Ishiura Y., Ito T., et al.Efficacy of gefapixant, a P2X3 antagonist, for lung cancer-related cough: a case report. International Medical Case Reports Journal 2023:16 497–501

Nomura S., Ito T., et al. Association of High Mobility Group Box-Protein 1 and Platelet-Microparticles in Patients After Hematopoietic Stem Cell Transplantation. Clin Appl Thromb Hemost. 2023 Jan-Dec:29:10760296231193398.

Nomura S., Ito T., et al. Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus. Clin Pharmacol. 2023 May 25:15:41-55.

Shimura U., Ito T., et al. Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum. Int J Hematol. 2023 Nov;118(5):609-617.

Uno S., Ito T., et al. Survival outcomes among patients with multiple myeloma in the era of novel agents: exploratory assessment using an electronic medical record database in Japan。. PLoS One . 2023 May 31;18(5):e0285947

Miyashita N.,Ito T,et al. Clinical efficacy of the neutralizing antibody therapy sotrovimab in patients with SARS-CoV-2 Omicron BA.1 and BA.2 subvariant infection. Viruses. 2023 May 31;15(6):1300.

Choi, I., Okada, M., Ito, T. Real-world data from yttrium-90 ibritumomab tiuxetan treatment of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma: J3Zi Study. Ann Hematol. 2023 May;102(5):1149-1158

Ishiura, Y., Nomura, S., Ishi, Y., Imai, K., Nakahama, K., Sawai, Y., Tamaki, T., Shimizu, T., Miyashita, N., Ito, T. Alectinib in a patient with ALK-positive non-small lung cancer unable to swallow capsules. Oncol Pharm Pract. 2023 Feb 5;10781552231155374.doi: 10.1177/10781552231155374. Online ahead of print.

Shimizu, Y. Ito, T. et al. Monocyte or white blood cell counts and ﾎｲ2 microglobulin predict the durable efficacy of daratumumab with lenalidomide. Ther Adv Hematol. 2022 Dec 13;13:20406207221142487. doi: 10.1177/20406207221142487. eCollection 2022.

Kuwana, M., Ito, T., et al. Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group study. Br J Haematol. 2023 Mar;200(6):802-811.doi: 10.1111/bjh.18582. Epub 2022 Dec 5.

Edahiro, Y., Ito, T., et al. Clinical characteristics of Japanese patients with polycythemia vera: Results of the JSH-MPN-R18 study. Int J Hematol 2022. 116: 696-711.

Tsubokura, Y., Ito, T., et al. Early administration of lenalidomide after allogeneic hematopoietic stem cell transplantation suppresses graft-versus-host disease by inhibiting T-cell migration to the gastrointestinal tract. Immun Inflamm Dis. 2022 Sep;10(9):e688.doi: 10.1002/iid3.688.

Onda, Y., Ito, T., et al. Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis. Ther Adv Hematol. 2022 Jun 24;13:20406207221104584. doi: 10.1177/20406207221104584. eCollection 2022.

Ito, T., Sanford, D., Tomuleasa, C., Hsiao, H. H., Olivera, L. J. E., Enjeti, A. K., Conca, A. G., Del Castillo, T. B., Girshova, L., Martelli, M. P., Guvenc, B., Bui, C. N., Delgado, A., Duan, Y., Guijarro, B. G., Llamas, C. and Lee, J. H. Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first-line systemic treatment or best supportive care: A multicenter international study. Eur J Haematol. Mar 17. doi: 10.1111/ejh.13769. 2022 Online ahead of print.

Yoshida, C., Kondo, T., Ito, T., Kizaki, M., Yamamoto, K., Miyamoto, T., Morita, Y., Eto, T., Katsuoka, Y., Takezako, N., Uoshima, N., Imada, K., Ando, J., Komeno, T., Mori, A., Ishikawa, Y., Satake, A., Watanabe, J., Kawakami, Y., Morita, T., Taneike, I., Nakayama, M., Duan, Y., Garbayo Guijarro, B., Delgado, A., Llamas, C. and Kiyoi, H. Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy. Int J Hematol . Apr 8. doi: 10.1007/s12185-022-03334-8. 2022 Online ahead of print.

Hashimoto Y, Ito T, et al: Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: The JSH-MPN-R18 study. Int J Hematol.2021; 115:208-221.

Hotta M, Ito T, et al: Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2021; 27: 660. e1-e8.

Establishment of a tumor sphere cell line from a metastatic brain neuroendocrine tumor. Medical molecular morphology 2017 Dec:50(4):211-219

Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment. Annals of oncology 2017 Jul:28:1532-1539

Immunohistochemical analysis of NANOG expression and epithelial-mesenchymal transition in pulmonary sarcomatoid carcinoma. Oncology letters 2017 May:13(5):3695-3702

Skin-derived TSLP systemically expands regulatory T cells. Journal of autoimmunity 2017 May:79:39-52

Thrombosis-related biomarkers in patients with multiple myeloma. International journal of laboratory hematology 2017:39(suppl2):102

Clinical significance of thrombosis-related biomarkers for patients with non-small-cell lung cancer. International journal of laboratory hematology 2017:39(suppl2):86

【ショック管理-ショックと臓器障害連関のメカニズム-】 ショック時の多臓器障害症候群を考える　遠隔臓器障害にマイクロパーティクルは関与する? 救急･集中治療 2017:29(5-6):351-356

Extracellular vesicles and blood diseases. International journal of hematology 2017 Apr:105(4):392-405

Changes of acute GVHD-related biomarkers after allogeneic hematopoietic stem cell transplantation. International journal of laboratory hematology 2017:39:129

Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations. Annals of oncology 2017 Jan:28(1):136-141

Circulating Free Tumor-derived DNA (ctDNA) Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: the ASSESS Study. Journal of thoracic oncology 2016 Oct:11(10):1682-1689

Endotoxemia-induced cytokine-mediated responses of hippocampal astrocytes transmitted by cells of the brain-immune interface. Scientific reports 2016 May 05:6:25457

Guanosine and its modified derivatives are endogenous ligands for TLR7. International immunology 2016 May:28(5):211-222

HMGB1は、後期糖化代謝産物受容体(RAGE)を介して活性化血小板に結合し、ヒトの冠動脈血栓内に多数存在する Angiology Frontier 2016 Apr:15(1):70-72

Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis. International journal of general medicine 2016 Apr 12:9:65-71

Increased recruitment of bone marrow-derived cells into the brain associated with altered brain cytokine profile in senescence-accelerated mice. Brain structure & function 2016 Apr:221(3):1513-1531

TCR signaling by conventional CD4+ T cells is required for optimal maintenance of peripheral regulatory T cell numbers. Immunity, inflammation and disease 2016 Mar 24:4(2):148-154

Plasma ctDNA for the detection of EGFR mutation status in advanced nsclc (aNSCLC) as per local diagnostic practices: Japanese subset data from assess. Pathology 2016 Feb:48 Suppl 1:S162

Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantation. Journal of blood medicine 2016 Jan 18:7:1-4

Microparticle and Atherothrombotic Diseases. Journal of atherosclerosis and thrombosis 2016:23(1):1-9

Induction and maintenance of Th2 immune responses by T-lymphocyte-derived microparticle. Current Trends in Immunology 2016:17:43-53

種々の核酸によるヒトミエロイド系樹状細胞から産生されるcytokineの検討 関西医科大学雑誌 2015:66:13-17

形質細胞様樹状細胞は、ICOSリガンドによるIL-10産生制御性T細胞誘導を促進するサイトカイン産生能を有する 関西医科大学雑誌 2015:66:19-24

Fetal thymus graft enables recovery from age-related hearing loss and expansion of CD4-Positive T cells expressing IL-1 receptor type 2 and regulatory T Cells. Immunity & Ageing 2015 Dec 15:12:Article No. 26

Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricema. Blood Coagulation & Fibrinolysis 2015 Dec:26(8):887-892

Chronic immune thrombocytopenia and semaphorin 5A. Thrombosis Research 2015 Nov:136(5):843-844

Associations between endothelial cell activation and acute GVHD after allogeneic hematopoietic stem cell transplantation. Current Trends in Immunology 2015:16:17-25

MESENCHYMAL TYPE GLIOMA STEM CELL EXPRESS ICOS LIGAND AND UPREGULATE ICOS+IL-10+T CELLS. Neuro-Oncology 2015 Nov:17(suppl 5):v116

制御性T細胞選択的増幅メカニズムを利用した免疫疾患制御へのアプローチ　新たな急性GVHD治療法開発の試み Cytometry Research 2015:25(2):7-13

Microparticles as biomarkers of blood coagulation in cancer. Biomarkers in Cancer 2015 Oct 1:7:51-56

マイクロパーティクル Thrombosis Medicine 2015:5(3):234-239

Microvesiclesと凝固・線溶, 血小板 Thrombosis Medicine 2015:5(3):251-254

Hypermethylation of MST1 in IgG4-related autoimmune pancreatitis and rheumatoid arthritis. Biochemical and Biophysical Research Communications 2015 Aug 7:463(4):968-974

造血幹細胞移植に関連した血管障害とバイオマーカー 日本造血細胞移植学会雑誌 2015:4(3):57-65

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity 2015 Mar:8:339-345

Platelet-derived RANK ligand enhances CCL17 secretion from dendritic cells mediated by thymic stromal lymphopoietin. Platelets 2015:26(5):425-431

多発性骨髄腫に対する人参養栄湯の免疫治療学的効果 Phil漢方 2015:53:9-11

スタチンの有する抗炎症効果 〜ヒト樹状細胞サブセットを治療ターケットとした新たな視点からの解析〜 Cytometry Research 2015 Apr:25:19-24

造血幹細胞移植における血管病変関連バイオメーカー Angiology Frontier :14(1):27-32

Clinical significance of procoagulant microparticles. Journal of Intensive Care 2015 Jan 7:3(1):Article No. 2

NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT. Blood 2015 Jun 4:125(23):3655-63

Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports. Journal of medical case reports 2014 8:250

Platelet-derived RANK ligand enhances CCL17 secretion from dendritic cells mediated by thymic stromal lymphopoietin.Platelets.2014 May27: 1-7

IL-33 Promotes the Induction and Maintenance of Th2 Immune Responses by Enhancing the Function of OX40 Ligand.Allergology international 2014 May 25

Serum interleukin-6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis. J. Rheumatology. 2013;40:1074–1081

Plasmacytoid dendritic cells have a rational cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming. Int.Immunol. 2013 25:171-182

Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS co-stimulation of Foxp3+ T regulatory cells. Cancer Res.2012 72:5240-5249

Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantation. International Medical Case Reports Journal. 2012 5:39-43

TGFβ(1) and sCTLA-4 levels are increased in eltrombopag-exposed patients with ITP. Thromb. Res. 2012 130:415-419

Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients. Int. J. Gen. Med. 2012 5:535-540

Effective intravenous immunoglobulin therapy for Churg-Strauss syndrome (allergic granulomatous angiitis) complicated by neuropathy of the eighth cranial nerve J Med Case Rep. 2012 6:310-312

Plasmacytoid dendritic cells and type I interferon as therapeutic cellular and molecular targets of autoimmune diseases Cytometry Research　2012 22:37-46,

Cellular and molecular mechanisms of TSLP function in human allergic disorders--TSLP programs the “Th2 code” in dendritic cells--. Allergology International, 2012　61, 35-43,

Antiplatelet antibody may cause delayed transfusion-related acute lung injury. International Journal of General Medicine. 2011 4:677-680

Spatial and temporal genetic heterogeneity of epidermal growth factor receptor gene status in a patient with non-small cell lung cancer: a case report. Journal of Medical Case Reports 2011 5:553-556

Platelet-derived microparticles cause CD154-dependent activation of dendritic cells. Platelets. 2011 23:81-82

Dynamic role of cell-derived microparticles in hematopoietic stem cell transplantation. Current Trends in Immunology. 2011 12：21-27

Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus. International Journal of General Medicine. 2011 4:539-545.

形質細胞様樹状細胞をターゲットとした自己免疫疾患治療の新たな治療戦略
臨床血液.2011 52:p521-530

CXCL8 enhances the angiogenic activity of umbilical cord blood-derived outgrowth endothelial cells in vitro. Cell Biol.lnt. 2011 35:201-208.

Can recombinant thrombomodulin play a preventive role for veno-occlusive disease after haematopoietic stem cell transplantation? Thromb Haemost. 2011 105:1118-1120.

The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy. Platelets. 2011 22：396-397

A case of rheumatoid pericarditis associated with a high IL-6 titer in the pericardial fluid and tocilizumab treatment. Mod Rheumatol. 2011 21:302-304.

Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA Peptide Complexes in Systemic Lupus Erythematosus. Sci Transl Med 2011: 3, 73ra19

Interferon-α and interleukin-12 are induced, respectively, by double-stranded DNA and single-stranded RNA in human myeloid dendritic cells. Immunology 2011: 132, 165-173

Conservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice. Biochem Biophys Res Commun. 2010: 397, 756-761

Inhibitor of IkB kinase activity, BAY11-7082, interferes with the IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cells Arthritis Research & Therapy 2010: 12, R87

Thymic stromal lymphopoietin plays an adjuvant role in BCG-mediated CD8+ cytotoxic T cell responses through dendritic cell activation Clin. Immunol. 2010: 136, 205-216

Statins, inhibitors of HMG-CoA reductase, function as inhibitors for cellular and molecular components involved in type I IFN production Arthritis & Rheumatism 2010: 62, 2073-2085

Dic (17;20) (p11;q11) preceded MLL gene amplification in a patient with de novo mixed-lineage leukemia. J Clin Exp Hematop. 2010: 50, 51-58

Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70. Blood. 2010: 115, 3051-3057

Thymic Stromal Lymphopoietin-Activated Plasmacytoid Dendritic Cells Induce the Generation of FOXP3+ Regulatory T Cells in Human Thymus.
J Immunol. 2010: 184, 2999-3007

The role of dendritic cell subsets in 2,4,6-trinitrobenzene sulfonic acid-induced ileitis Journal of Autoimmunity 2010: 34, 380-389

Decrease of blood dendritic cells and increase of tissue-infiltrating dendritic cells are involved in the induction of Sjogren's syndrome but not in the maintenance. Clin Exp Immunol. 2010: 159, 315-326

Adult T-cell leukemia after immunosuppressive therapy for systemic lupus erythematosus. Int J Hematol 2009: 89, 128-129

Successful treatment with plasma exchange in adult-onset Still's disease with hyper-IL-18-naemia and hyperallergic state. Mod Rheumatol 2008: 18, 407-410

Imidazoquinoline acts as immune adjuvant for functional alteration of thymic stromal lymphopoietin-mediated allergic T cell response. J Immunol 2008: 181, 5340-5349

Mycobacterium bovis Bacillus Calmette-Guerin suppresses inflammatory Th2 responses by inducing functional alteration of TSLP-activated dendritic cells. Int Immunol 2008: 20, 1321-1329

Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12. J Immunol 2008: 180, 6000-6009

Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 2008: 28, 870-880

Three cases of polymyositis/dermatomyositis complicated by pneumomediastinum. Nihon Rinsho Meneki Gakkai Kaishi 2008: 31, 56-61

Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma. Proc Natl Acad Sci U S A 2007: 104, 20884-20889

Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells. J Leukoc Biol 2007: 82, 576-584

TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 2007: 25, 193-219

Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med 2007: 204, 105-115

Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells. Immunology 2006: 119, 36-42

Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 2006: 24, 827-838

Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 2006: 107, 2423-2431

OX40 ligand shuts down IL-10-producing regulatory T cells. Proc Natl Acad Sci U S A 2006: 103, 13138-13143

Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood 2006: 107, 3617-3623

Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med 2006: 203, 1399-1405

Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005: 436, 1181-1185

Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol 2005: 26, 221-229

Functional diversity and plasticity of human dendritic cell subsets. Int J Hematol 2005: 81, 188-196

TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005: 202, 1213-1223

IL-4-producing CD8(+) T cells may be an immunological hallmark of chronic GVHD. Bone Marrow Transplant 2005: 36, 639-647

Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs. J Immunol 2004: 172, 4253-4259

Involvement of dendritic cells in sarcoidosis. Thorax 2004: 59, 408-413

Blood dendritic cells are decreased in acute graft-versus-host disease. Bone Marrow Transplant 2004: 33, 989-996

Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets. Immunology 2003: 108, 321-328

Analyses of dendritic cell subsets in pregnancy. Am J Reprod Immunol 2003: 50, 137-145

Dendritic cells are decreased in blood and accumulated in granuloma in tuberculosis. Clin Immunol 2002: 105, 296-303

Roles of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance. Hum Immunol 2002: 63, 1120-1125

Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 2002: 195, 1507-1512

Comparison of bone marrow cells harvested from various bones of cynomolgus monkeys at various ages by perfusion or aspiration methods: a preclinical study for human BMT. Stem Cells 2002: 20, 155-162

Marked increase in number of dendritic cells in autoimmune-prone (NZW x BXSB)F1 mice with age. Stem Cells 2002: 20, 61-72

Hodgkin's disease cell line, KM-H2, shows biphenotypic features of dendritic cells and B cells. Int J Hematol 2001: 73, 236-244

Alteration of peripheral blood dendritic cells in patients with primary Sjogren's syndrome. Arthritis Rheum 2001: 44, 419-431

Differential regulation of human blood dendritic cell subsets by IFNs. J Immunol 2001: 166, 2961-2969

A novel strategy for organ allografts using sublethal (7 Gy) irradiation followed by injection of donor bone marrow cells via portal vein. Transplantation 2001: 71, 1725-1731

A new method for bone marrow cell harvesting. Stem Cells 2000: 18, 453-456

Development of mouse dendritic cells from lineage-negative c-kit(low) pluripotent hemopoietic stem cells in vitro. Stem Cells 2000: 18, 53-60

Comparative analyses of megakaryocytes derived from cord blood and bone marrow. Br J Haematol 2000: 108, 602-609

A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol 1999: 163, 1409-1419

Experimental autoimmune thyroiditis induced by thyroglobulin-pulsed dendritic cells. Autoimmunity 2000: 31, 273-282

HGF activates signal transduction from EPO receptor on human cord blood CD34+/CD45+ cells. Stem Cells 1999: 17, 82-91

[A pharmacokinetic study of the value of oral cytarabine ocfosfate in the treatment of hematological malignancies]. Rinsho Ketsueki 1998: 39, 348-354

Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997: 19, 1041-1043